Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3759398010 | Tagraxofusp-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3759399019 | Product containing tagraxofusp in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing tagraxofusp in parenteral dose form (medicinal product form) | Is a | Product containing tagraxofusp (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing tagraxofusp in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing tagraxofusp in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing tagraxofusp in parenteral dose form (medicinal product form) | Has active ingredient | Tagraxofusp | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing tagraxofusp in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only tagraxofusp in parenteral dose form (medicinal product form) | Is a | True | Product containing tagraxofusp in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR